http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104388453-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-187 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-295 |
| filingDate | 2014-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104388453-B |
| titleOfInvention | Porcine circovirus (PCV) cap protein inserted swine fever virus B cell epitope recombinant virus and application thereof |
| abstract | The invention discloses a porcine circovirus (PCV) cap protein inserted swine fever virus B cell epitope recombinant virus and application thereof. A synthetic cap-24 gene is expressed in a baculovirus transfer vector pH promoter to obtain the recombinant baculovirus (CCTCC NO:V201432). When being used for immunizing a mouse, the subunit vaccine prepared from the inserted PCV2 VLP protein expressed by the recombinant baculovirus can induce the organism to generate the specific humoral immunity and can generate the specific antibody level against CSFV and PCV2. The invention provides a favorable candidate vaccine for simultaneously controlling the two diseases in clinic, and also provides feasibility test data for researching expression of other exogenous antigens by using circovirus as a vector. |
| priorityDate | 2014-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 185.